Hims & Hers Health IPO
Hims & Hers Health is a direct-to-consumer telehealth platform offering treatments for various health conditions including hair loss, erectile dysfunction, skincare, and mental health. The company provides online consultations with healthcare providers and delivers prescription medications directly to consumers. It represents a major player in the digital health and telemedicine space.
What We Know
Hims & Hers Health went public in January 2021 through a SPAC merger with Oaktree Acquisition Corp, initially trading under the ticker symbol HIMS on the NYSE. The company began trading at around $10-12 per share following the SPAC transaction. The stock has experienced significant volatility since going public, with shares reaching highs above $25 in early 2021 before declining substantially. Since going public, the company has focused on expanding its service offerings and customer base while working toward profitability. The stock performance has been influenced by broader market sentiment toward telehealth companies and growth stocks. Investors have been watching the company's ability to scale its operations and achieve sustainable growth in the competitive direct-to-consumer healthcare market.
Frequently Asked Questions
Has Hims & Hers Health had an IPO?
Yes, Hims & Hers Health completed its IPO through a SPAC merger in January 2021. The company has been publicly traded on the NYSE under the ticker HIMS since then.
When is the Hims & Hers Health IPO date?
Hims & Hers Health already completed its public debut in January 2021 via SPAC merger. The company is currently trading on public markets.
How can I buy Hims & Hers Health stock?
You can buy Hims & Hers stock through any broker that offers NYSE-listed stocks under the ticker symbol HIMS. The stock is available for purchase during regular trading hours and through most online brokerages.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts